Trials / Conditions / Focal Seizure
Focal Seizure
6 registered clinical trials studyying Focal Seizure — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures NCT07219407 | Rapport Therapeutics Inc. | Phase 2 |
| Enrolling By Invitation | Clinical Trial of Vormatrigine in Adult Patients With Epilepsy NCT07287163 | Praxis Precision Medicines | Phase 3 |
| Active Not Recruiting | Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007 NCT06899230 | iQure Australia Pty Ltd | Phase 1 |
| Recruiting | Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWE NCT06999902 | Praxis Precision Medicines | Phase 2 / Phase 3 |
| Completed | Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy NCT04770337 | Neuroelectrics Corporation | N/A |
| Unknown | Randomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS NCT04557085 | SK Life Science, Inc. | Phase 3 |